PSAP-positive extra-prostatic cancers included 3 of 94 (3.2%) neuroendocrine tumors of the pancreas and 1 of 129 (0.8%) gastric adenocarcinomas (Table 1, Supplementary Figure S1). This evidence concerns the gene PSAP and pancreatic neuroendocrine tumor.